Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
35
Number of overlapping holdings
39.8%
% of WDNA's 91 holdings also in XBI
25.7%
% of XBI's 136 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.2% | 3.5% | 2.2% |
|
BLUEPRINT MEDICINES CORP. | 2.6% | 1.7% | 1.7% |
|
SAREPTA THERAPEUTICS INC | 1.7% | 2.7% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 1.6% | 2.6% | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.5% | 2.9% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to XBI
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.7% |
|
FATE THERAPEUTICS INC | 2.1% |
|
ELI LILLY & CO | 2.1% |
|
AGIOS PHARMACEUTICALS INC | 1.8% |
|
VERICEL CORPORATION | 1.6% |
|
GERON CORP | 1.6% |
|
DANAHER CORP | 1.4% |
|
CATALENT INC | 1.3% |
 |
NOVARTIS AG | 1.3% |
WDNA Underweight Relative to XBI
|
INCYTE CORP | -2.9% |
|
ADVENTRX PHARMACEUTICALS INC | -2.8% |
|
NEUROCRINE BIOSCIENCES INC | -2.8% |
|
INSMED INC | -2.6% |
|
ABBVIE INC | -2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.2% |
|
GILEAD SCIENCES INC | -1.9% |
|
VIKING THERAPEUTICS, INC. | -1.9% |
|
TG THERAPEUTICS INC | -1.7% |
|
EXACT SCIENCES CORP | -1.7% |